NEK5 activity regulates the mesenchymal and migratory phenotype in breast cancer cells.
Saved in:
| Title: | NEK5 activity regulates the mesenchymal and migratory phenotype in breast cancer cells. |
|---|---|
| Authors: | Matossian MD; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Elliott S; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Van Hoang T; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Burks HE; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Wright MK; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Alzoubi MS; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Yan T; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Chang T; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Wathieu H; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Windsor GO; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Hartono AB; Department of Pathology, Tulane University School of Medicine, New Orleans, LA, USA., Lee S; Department of Pathology, Tulane University School of Medicine, New Orleans, LA, USA., Zuercher WJ; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Drewry DH; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Wells C; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Kapadia N; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Buechlein A; Indiana University Center for Genomics and Bioinformatics, Bloomington, IN, USA., Fang F; Indiana University Center for Genomics and Bioinformatics, Bloomington, IN, USA., Nephew KP; Indiana University Center for Genomics and Bioinformatics, Bloomington, IN, USA.; Medical Sciences Program, Indiana University School of Medicine-Bloomington, Bloomington, IN, USA., Collins-Burow BM; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Burow ME; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA. mburow@tulane.edu. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Aug; Vol. 189 (1), pp. 49-61. Date of Electronic Publication: 2021 Jul 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7217 |
|---|---|
| DOI: | 10.1007/s10549-021-06295-4 |